Skip to main content
NCBI home page
Gut logoLink to Gut
. 1999 Apr;44(4):575–578. doi: 10.1136/gut.44.4.575

Hepatitis C virus recurrence after liver transplantation

T BIZOLLON 1, C DUCERF 1, C TREPO 1, D MUTIMER 1
PMCID: PMC1727446  PMID: 10075968

Abstract

Hepatology and Liver Transplantation Unit,Hôtel-Dieu Croix-Rousse,Lyon,France

D MUTIMER

Cirrhosis due to hepatitis C virus (HCV) is now the most common indication of liver transplantation in Western Europe and the United States. In the absence of effective prophylaxis, recurrent HCV infection is almost inevitable. Though the natural history and intermediate term outcome of recurrent HCV are now better documented, those factors which may influence the recurrence of hepatitis and consequent progression of graft disease remain unclear. Interferon (IFN) as a sole agent for the treatment of recurrent infection has proved unsatisfactory. Early intervention with a combination of IFN and ribavirin seems promising, and this approach may prevent or delay progression of HCV related graft disease after liver transplantation. 



Full Text

The Full Text of this article is available as a PDF (94.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ascher N. L. The role of the host immune state in recurrent hepatitis C. Liver Transpl Surg. 1997 Mar;3(2):179–180. doi: 10.1002/lt.500030213. [DOI] [PubMed] [Google Scholar]
  2. Berenguer M., Terrault N. A., Piatak M., Yun A., Kim J. P., Lau J. Y., Lake J. R., Roberts J. R., Ascher N. L., Ferrell L. Hepatitis G virus infection in patients with hepatitis C virus infection undergoing liver transplantation. Gastroenterology. 1996 Dec;111(6):1569–1575. doi: 10.1016/s0016-5085(96)70019-7. [DOI] [PubMed] [Google Scholar]
  3. Bizollon T., Guichard S., Ahmed S. N., Chevallier P., Ducerf C., Sepetjan M., Baulieux J., Trepo C. Impact of hepatitis G virus co-infection on the course of hepatitis C virus infection before and after liver transplantation. J Hepatol. 1998 Dec;29(6):893–900. doi: 10.1016/s0168-8278(98)80116-5. [DOI] [PubMed] [Google Scholar]
  4. Bizollon T., Palazzo U., Ducerf C., Chevallier M., Elliott M., Baulieux J., Pouyet M., Trepo C. Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation. Hepatology. 1997 Aug;26(2):500–504. doi: 10.1002/hep.510260236. [DOI] [PubMed] [Google Scholar]
  5. Böker K. H., Dalley G., Bahr M. J., Maschek H., Tillmann H. L., Trautwein C., Oldhaver K., Bode U., Pichlmayr R., Manns M. P. Long-term outcome of hepatitis C virus infection after liver transplantation. Hepatology. 1997 Jan;25(1):203–210. doi: 10.1002/hep.510250137. [DOI] [PubMed] [Google Scholar]
  6. Calmus Y., Hannoun L., Dousset B., Wolff P., Miguet J. P., Doffoel M., Gillet M., Cinqualbre J., Poupon R., Houssin D. HLA class I matching is responsible for the hepatic lesions in recurrent viral hepatitis B after liver transplantation. Transplant Proc. 1990 Oct;22(5):2311–2313. [PubMed] [Google Scholar]
  7. Cattral M. S., Krajden M., Wanless I. R., Rezig M., Cameron R., Greig P. D., Chung S. W., Levy G. A. A pilot study of ribavirin therapy for recurrent hepatitis C virus infection after liver transplantation. Transplantation. 1996 May 27;61(10):1483–1488. doi: 10.1097/00007890-199605270-00013. [DOI] [PubMed] [Google Scholar]
  8. Chazouilleres O., Kim M., Combs C., Ferrell L., Bacchetti P., Roberts J., Ascher N. L., Neuwald P., Wilber J., Urdea M. Quantitation of hepatitis C virus RNA in liver transplant recipients. Gastroenterology. 1994 Apr;106(4):994–999. doi: 10.1016/0016-5085(94)90759-5. [DOI] [PubMed] [Google Scholar]
  9. Cotler S. J., Gretch D. R., Bronner M. P., Tateyama H., Emond M. J., dela Rosa C., Perkins J. D., Carithers R. L., Jr Hepatitis G virus co-infection does not alter the course of recurrent hepatitis C virus infection in liver transplantation recipients. Hepatology. 1997 Aug;26(2):432–436. doi: 10.1002/hep.510260225. [DOI] [PubMed] [Google Scholar]
  10. Di Bisceglie A. M., Goodman Z. D., Ishak K. G., Hoofnagle J. H., Melpolder J. J., Alter H. J. Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. Hepatology. 1991 Dec;14(6):969–974. doi: 10.1016/0270-9139(91)90113-a. [DOI] [PubMed] [Google Scholar]
  11. Di Bisceglie A. M. Hepatitis C and hepatocellular carcinoma. Semin Liver Dis. 1995 Feb;15(1):64–69. doi: 10.1055/s-2007-1007263. [DOI] [PubMed] [Google Scholar]
  12. Ferrell L. D., Wright T. L., Roberts J., Ascher N., Lake J. Hepatitis C viral infection in liver transplant recipients. Hepatology. 1992 Oct;16(4):865–876. doi: 10.1002/hep.1840160403. [DOI] [PubMed] [Google Scholar]
  13. Féray C., Gigou M., Samuel D., Paradis V., Mishiro S., Maertens G., Reynés M., Okamoto H., Bismuth H., Bréchot C. Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology. 1995 Apr;108(4):1088–1096. doi: 10.1016/0016-5085(95)90207-4. [DOI] [PubMed] [Google Scholar]
  14. Féray C., Gigou M., Samuel D., Paradis V., Wilber J., David M. F., Urdea M., Reynes M., Bréchot C., Bismuth H. The course of hepatitis C virus infection after liver transplantation. Hepatology. 1994 Nov;20(5):1137–1143. doi: 10.1002/hep.1840200506. [DOI] [PubMed] [Google Scholar]
  15. Féray C., Samuel D., Gigou M., Paradis V., David M. F., Lemonnier C., Reynès M., Bismuth H. An open trial of interferon alfa recombinant for hepatitis C after liver transplantation: antiviral effects and risk of rejection. Hepatology. 1995 Oct;22(4 Pt 1):1084–1089. [PubMed] [Google Scholar]
  16. Féray C., Samuel D., Thiers V., Gigou M., Pichon F., Bismuth A., Reynes M., Maisonneuve P., Bismuth H., Bréchot C. Reinfection of liver graft by hepatitis C virus after liver transplantation. J Clin Invest. 1992 Apr;89(4):1361–1365. doi: 10.1172/JCI115723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Gane E. J., Naoumov N. V., Qian K. P., Mondelli M. U., Maertens G., Portmann B. C., Lau J. Y., Williams R. A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology. 1996 Jan;110(1):167–177. doi: 10.1053/gast.1996.v110.pm8536853. [DOI] [PubMed] [Google Scholar]
  18. Gane E. J., Portmann B. C., Naoumov N. V., Smith H. M., Underhill J. A., Donaldson P. T., Maertens G., Williams R. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med. 1996 Mar 28;334(13):815–820. doi: 10.1056/NEJM199603283341302. [DOI] [PubMed] [Google Scholar]
  19. Gane E. J., Tibbs C. J., Ramage J. K., Portmann B. C., Williams R. Ribavirin therapy for hepatitis C infection following liver transplantation. Transpl Int. 1995;8(1):61–64. doi: 10.1007/BF00366714. [DOI] [PubMed] [Google Scholar]
  20. Heagy W., Crumpacker C., Lopez P. A., Finberg R. W. Inhibition of immune functions by antiviral drugs. J Clin Invest. 1991 Jun;87(6):1916–1924. doi: 10.1172/JCI115217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Jolley W. B., Sharma B., Chami R., Ng C., Bullington R. Long-term skin allograft survival by combined therapy with suboptimal dose of cyclosporine and ribavirin. Transplant Proc. 1988 Aug;20(4):703–706. [PubMed] [Google Scholar]
  22. Knoop M., Bechstein W. O., Blumhardt G., Langrehr J. M., Berg T., König V., Wedell A., Hopf U., Neuhaus P. Recurrent hepatitis C infection after orthotopic liver transplantation. Transplant Proc. 1995 Feb;27(1):1208–1210. [PubMed] [Google Scholar]
  23. Kuo G., Choo Q. L., Alter H. J., Gitnick G. L., Redeker A. G., Purcell R. H., Miyamura T., Dienstag J. L., Alter M. J., Stevens C. E. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science. 1989 Apr 21;244(4902):362–364. doi: 10.1126/science.2496467. [DOI] [PubMed] [Google Scholar]
  24. König V., Bauditz J., Lobeck H., Lüsebrink R., Neuhaus P., Blumhardt G., Bechstein W. O., Neuhaus R., Steffen R., Hopf U. Hepatitis C virus reinfection in allografts after orthotopic liver transplantation. Hepatology. 1992 Nov;16(5):1137–1143. doi: 10.1002/hep.1840160506. [DOI] [PubMed] [Google Scholar]
  25. Larrea E., Garcia N., Qian C., Civeira M. P., Prieto J. Tumor necrosis factor alpha gene expression and the response to interferon in chronic hepatitis C. Hepatology. 1996 Feb;23(2):210–217. doi: 10.1002/hep.510230203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Lim H. L., Lau G. K., Davis G. L., Dolson D. J., Lau J. Y. Cholestatic hepatitis leading to hepatic failure in a patient with organ-transmitted hepatitis C virus infection. Gastroenterology. 1994 Jan;106(1):248–251. doi: 10.1016/s0016-5085(94)95829-7. [DOI] [PubMed] [Google Scholar]
  27. Loinaz C., Lumbreras C., González-Pinto I., Colina F., Gómez R., Fuertes A., Alvarado A., García I., Noriega A. R., Moreno E. High incidence of posttransplant hepatitis and chronic rejection associated with hepatitis C virus infection in liver transplant recipients. Transplant Proc. 1995 Feb;27(1):1217–1218. [PubMed] [Google Scholar]
  28. Martell M., Esteban J. I., Quer J., Vargas V., Esteban R., Guardia J., Gómez J. Dynamic behavior of hepatitis C virus quasispecies in patients undergoing orthotopic liver transplantation. J Virol. 1994 May;68(5):3425–3436. doi: 10.1128/jvi.68.5.3425-3436.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Martin P., Muñoz S. J., Di Bisceglie A. M., Rubin R., Waggoner J. G., Armenti V. T., Moritz M. J., Jarrell B. E., Maddrey W. C. Recurrence of hepatitis C virus infection after orthotopic liver transplantation. Hepatology. 1991 Apr;13(4):719–721. [PubMed] [Google Scholar]
  30. Poterucha J. J., Rakela J., Lumeng L., Lee C. H., Taswell H. F., Wiesner R. H. Diagnosis of chronic hepatitis C after liver transplantation by the detection of viral sequences with polymerase chain reaction. Hepatology. 1992 Jan;15(1):42–45. doi: 10.1002/hep.1840150109. [DOI] [PubMed] [Google Scholar]
  31. Read A. E., Donegan E., Lake J., Ferrell L., Galbraith C., Kuramoto I. K., Zeldis J. B., Ascher N. L., Roberts J., Wright T. L. Hepatitis C in patients undergoing liver transplantation. Ann Intern Med. 1991 Feb 15;114(4):282–284. doi: 10.7326/0003-4819-114-4-282. [DOI] [PubMed] [Google Scholar]
  32. Rosen H. R., Chou S., Corless C. L., Gretch D. R., Flora K. D., Boudousquie A., Orloff S. L., Rabkin J. M., Benner K. G. Cytomegalovirus viremia: risk factor for allograft cirrhosis after liver transplantation for hepatitis C. Transplantation. 1997 Sep 15;64(5):721–726. doi: 10.1097/00007890-199709150-00010. [DOI] [PubMed] [Google Scholar]
  33. Schluger L. K., Sheiner P. A., Thung S. N., Lau J. Y., Min A., Wolf D. C., Fiel I., Zhang D., Gerber M. A., Miller C. M. Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. Hepatology. 1996 May;23(5):971–976. doi: 10.1002/hep.510230505. [DOI] [PubMed] [Google Scholar]
  34. Sheiner P. A., Schluger L. K., Emre S., Thung S. N., Lau J. Y., Guy S. R., Schwartz M. E., Miller C. M. Retransplantation for recurrent hepatitis C. Liver Transpl Surg. 1997 Mar;3(2):130–136. doi: 10.1002/lt.500030205. [DOI] [PubMed] [Google Scholar]
  35. Sheiner P. A., Schwartz M. E., Mor E., Schluger L. K., Theise N., Kishikawa K., Kolesnikov V., Bodenheimer H., Emre S., Miller C. M. Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation. Hepatology. 1995 Jan;21(1):30–34. [PubMed] [Google Scholar]
  36. Shuhart M. C., Bronner M. P., Gretch D. R., Thomassen L. V., Wartelle C. F., Tateyama H., Emerson S. S., Perkins J. D., Carithers R. L., Jr Histological and clinical outcome after liver transplantation for hepatitis C. Hepatology. 1997 Dec;26(6):1646–1652. doi: 10.1002/hep.510260638. [DOI] [PubMed] [Google Scholar]
  37. Singh N., Gayowski T., Wagener M. M., Marino I. R. Increased infections in liver transplant recipients with recurrent hepatitis C virus hepatitis. Transplantation. 1996 Feb 15;61(3):402–406. doi: 10.1097/00007890-199602150-00014. [DOI] [PubMed] [Google Scholar]
  38. Tinè F., Magrin S., Craxì A., Pagliaro L. Interferon for non-A, non-B chronic hepatitis. A meta-analysis of randomised clinical trials. J Hepatol. 1991 Sep;13(2):192–199. doi: 10.1016/0168-8278(91)90814-r. [DOI] [PubMed] [Google Scholar]
  39. Weiner A. J., Brauer M. J., Rosenblatt J., Richman K. H., Tung J., Crawford K., Bonino F., Saracco G., Choo Q. L., Houghton M. Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. Virology. 1991 Feb;180(2):842–848. doi: 10.1016/0042-6822(91)90104-j. [DOI] [PubMed] [Google Scholar]
  40. Weinstein J. S., Poterucha J. J., Zein N., Wiesner R. H., Persing D. H., Rakela J. Epidemiology and natural history of hepatitis C infections in liver transplant recipients. J Hepatol. 1995;22(1 Suppl):154–159. [PubMed] [Google Scholar]
  41. Wright H. I., Gavaler J. S., Van Theil D. H. Preliminary experience with alpha-2b-interferon therapy of viral hepatitis in liver allograft recipients. Transplantation. 1992 Jan;53(1):121–124. doi: 10.1097/00007890-199201000-00023. [DOI] [PubMed] [Google Scholar]
  42. Wright T. L., Combs C., Kim M., Ferrell L., Bacchetti P., Ascher N., Roberts J., Wilber J., Sheridan P., Urdea M. Interferon-alpha therapy for hepatitis C virus infection after liver transplantation. Hepatology. 1994 Oct;20(4 Pt 1):773–779. doi: 10.1002/hep.1840200402. [DOI] [PubMed] [Google Scholar]
  43. Wright T. L., Donegan E., Hsu H. H., Ferrell L., Lake J. R., Kim M., Combs C., Fennessy S., Roberts J. P., Ascher N. L. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology. 1992 Jul;103(1):317–322. doi: 10.1016/0016-5085(92)91129-r. [DOI] [PubMed] [Google Scholar]
  44. Zhou S., Terrault N. A., Ferrell L., Hahn J. A., Lau J. Y., Simmonds P., Roberts J. P., Lake J. R., Ascher N. L., Wright T. L. Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia. Hepatology. 1996 Nov;24(5):1041–1046. doi: 10.1002/hep.510240510. [DOI] [PubMed] [Google Scholar]
  45. el-Ashmawy L., Hassanein T., Gavaler J. S., Van Thiel D. H. Prevalence of hepatitis C virus antibody in a liver transplantation population. Dig Dis Sci. 1992 Jul;37(7):1110–1115. doi: 10.1007/BF01300295. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES